Literature DB >> 18063662

The kinetics of competitive antagonism of nicotinic acetylcholine receptors at physiological temperature.

Deeptankar Demazumder1, James P Dilger.   

Abstract

Detailed information about the ligand-binding site of nicotinic acetylcholine receptors has emerged from structural and mutagenesis experiments. However, these approaches provide only static images of ligand-receptor interactions. Kinetic measurements of changes in protein function are needed to develop a more dynamic picture. Previously, we measured association and dissociation rate constants for competitive inhibition of current through embryonic muscle acetylcholine receptor channels at 25 degrees C. Little is known about competitive antagonism at physiological temperatures. Here, we performed measurements at 37 degrees C and used thermodynamics to estimate the energetics of antagonism. We used rapid solution exchange protocols to determine equilibrium and kinetics of inhibition of acetylcholine-activated currents in outside-out patches by (+)-tubocurarine, pancuronium and cisatracurium. Kinetic rates as high as 600 s(-1) were resolved by this technique. Binding was primarily enthalpy driven. The 12 degrees C increase in temperature decreased equilibrium antagonist binding by 1.7- to 1.9-fold. In contrast, association and dissociation rate constants increased 1.9- to 6.0-fold. Activation energies for dissociation were 90 +/- 6, 106 +/- 8 and 116 +/- 10 kJ mol(-1) for cisatracurium, (+)-tubocurarine and pancuronium, respectively. The corresponding apparent activation energies for association were 38 +/- 6, 85 +/- 6 and 107 +/- 13 kJ mol(-1). The higher activation energy for association of (+)-tubocurarine and pancuronium compared with cisatracurium is notable. This may arise from either a more superficial binding site for the large antagonist cisatracurium compared to the other ligands, or from a change in receptor conformation upon binding of (+)-tubocurarine and pancuronium but not cisatracurium. Differences in ligand desolvation and ligand conformation are not likely to be important.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18063662      PMCID: PMC2375649          DOI: 10.1113/jphysiol.2007.143289

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  39 in total

1.  The kinetics of competitive antagonism by cisatracurium of embryonic and adult nicotinic acetylcholine receptors.

Authors:  D Demazumder; J P Dilger
Journal:  Mol Pharmacol       Date:  2001-10       Impact factor: 4.436

2.  The kinetics of inhibition of nicotinic acetylcholine receptors by (+)-tubocurarine and pancuronium.

Authors:  I Wenningmann; J P Dilger
Journal:  Mol Pharmacol       Date:  2001-10       Impact factor: 4.436

3.  Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.

Authors:  K Brejc; W J van Dijk; R V Klaassen; M Schuurmans; J van Der Oost; A B Smit; T K Sixma
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

4.  GABA(A) receptor beta 2 Tyr97 and Leu99 line the GABA-binding site. Insights into mechanisms of agonist and antagonist actions.

Authors:  Andrew J Boileau; J Glen Newell; Cynthia Czajkowski
Journal:  J Biol Chem       Date:  2001-11-15       Impact factor: 5.157

5.  Curariform antagonists bind in different orientations to acetylcholine-binding protein.

Authors:  Fan Gao; Nina Bern; Alicia Little; Hai-Long Wang; Scott B Hansen; Todd T Talley; Palmer Taylor; Steven M Sine
Journal:  J Biol Chem       Date:  2003-04-07       Impact factor: 5.157

6.  Crystal structure of a Cbtx-AChBP complex reveals essential interactions between snake alpha-neurotoxins and nicotinic receptors.

Authors:  Yves Bourne; Todd T Talley; Scott B Hansen; Palmer Taylor; Pascale Marchot
Journal:  EMBO J       Date:  2005-03-24       Impact factor: 11.598

7.  Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations.

Authors:  Scott B Hansen; Gerlind Sulzenbacher; Tom Huxford; Pascale Marchot; Palmer Taylor; Yves Bourne
Journal:  EMBO J       Date:  2005-09-29       Impact factor: 11.598

8.  Lysine scanning mutagenesis delineates structural model of the nicotinic receptor ligand binding domain.

Authors:  Steven M Sine; Hai-Long Wang; Nina Bren
Journal:  J Biol Chem       Date:  2002-05-13       Impact factor: 5.157

9.  Curariform antagonists bind in different orientations to the nicotinic receptor ligand binding domain.

Authors:  Hai-Long Wang; Fan Gao; Nina Bren; Steven M Sine
Journal:  J Biol Chem       Date:  2003-06-10       Impact factor: 5.157

10.  Tryptophan fluorescence reveals conformational changes in the acetylcholine binding protein.

Authors:  Scott B Hansen; Zoran Radic'; Todd T Talley; Brian E Molles; Tom Deerinck; Igor Tsigelny; Palmer Taylor
Journal:  J Biol Chem       Date:  2002-09-13       Impact factor: 5.157

View more
  5 in total

1.  Monte Carlo simulation of buffered diffusion into and out of a model synapse.

Authors:  James P Dilger
Journal:  Biophys J       Date:  2010-03-17       Impact factor: 4.033

2.  The Path of an Early Career Physician and Scientist in Cardiac Electrophysiology.

Authors:  Deeptankar DeMazumder
Journal:  Circ Res       Date:  2018-12-07       Impact factor: 17.367

3.  Simulation of the kinetics of neuromuscular block: implications for speed of onset.

Authors:  James P Dilger
Journal:  Anesth Analg       Date:  2013-03-01       Impact factor: 5.108

4.  Site selectivity of competitive antagonists for the mouse adult muscle nicotinic acetylcholine receptor.

Authors:  Man Liu; James P Dilger
Journal:  Mol Pharmacol       Date:  2008-10-08       Impact factor: 4.436

5.  Synergy between pairs of competitive antagonists at adult human muscle acetylcholine receptors.

Authors:  Man Liu; James P Dilger
Journal:  Anesth Analg       Date:  2008-08       Impact factor: 5.108

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.